Day One Biopharmaceuticals, INC. (DAWN) — 10-K/A Filings
All 10-K/A filings from Day One Biopharmaceuticals, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Day One Bio files 10-K/A amendment
— Mar 6, 2025 Risk: low
Day One Biopharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2024. The filing, submitted on March 6
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX